3rd Next Generation Gene Therapy Vectors Summit
-
Location:
- Hilton Boston Back Bay
- Dalton Street
- Boston
- Massachusetts
- 02115
- United States
- View on a map
- More Information:
-
Contact:
- Organiser: Hanson Wade
- Name: Customer Services
- Email: info@hansonwade.com
- Telephone: +16174554188
As the biggest industry-led meeting on novel vector development, the 3rd Annual Next Generation Gene Therapy Vectors Summit (https://ter.li/bv6v3u) (June 27-29, 2023 | Boston, MA) will bring together 100+ key opinion leaders to help solve the safety, efficiency, and scalability challenges of the next generation of vectors.
Industry heavyweights such as Novartis, Spark Therapeutics, Capsida Biotherapeutics, and Dyno Therapeutics will deliver data-led seminars, workshops, and panels to aid in the progression of promising vector designs from discovery to clinical trials.
Download the brochure to see the full agenda - https://ter.li/vek5z5
Uniting industry pioneers such as Dave Chu (Capsida Biotherapeutics), Sean Armour (Spark Therapeutics), Eric Kelsic (Dyno Therapeutics), Jing Liao (Alexion Pharmaceuticals), and others – this summit will be your ultimate roadmap to the future of the industry as it upgrades to the next generation of vectors.
Register to attend - https://ter.li/lyw7a7
URL:
Brochure: https://go.evvnt.com/1539510-0?pid=185
Prices:
Conference + Workshop Day: USD 4996.00,
Conference Only: USD 3199.00
Speakers: Aditya Wakankar, Sangamo Therapeutics, Arun Srivastava, University of Florida, Barbara Sanders, VectorY, Ben Deverman, The Broad Institute of MIT and Harvard, Bob Getts, Code Biotherapeutics, Dave Chu, Capsida Biotherapeutics, David Huss, Shape Therapeutics, Eduard Ayuso, DINAQOR, Eric Kelsic, Dyno Therapeutics, Greg Sarek, EG 427, Hemant Khanna, IVERIC bio, Jing Liao, Alexion Pharmaceuticals, John Thompson, Homology Medicines, Josef el Andari, DiNAQOR, Joseph La Barge, Apertura Gene Therapy, Josephine Joel, Gyroscope Therapeutics, Jun Xie, UMass Medical School, Keith R. Lange, Spark Therapeutics, Leszek Lisowski, The University of Sydney, Michele Stone, Kriya Therapeutics, Nerea Zabaleta, Harvard Medical School and Mass Eye and Ear, Ozan Alkan, Carmine Therapeutics, Peter de Haan, Amarna Therapeutics, Rodolphe Clerval, Coave Therapeutics, Sean Armour, Spark Therapeutics, Sisi Chen, Apertura Gene Therapy, Wayne Yount, Kriya Therapeutics
Time: 8:00 am to 5:00 pm